Concepedia

Author

Ian Ganly

Memorial Sloan Kettering Cancer CenterORCID

Also Known As

Alpert N, Baselga, José, Bryan Fuchs, Ganly, Ian, I Ganly, I. Ganly, Iain Nixon, Ian Ganly, Ian S. Ganly, James Glasbey

765

Publications

31.4K

Citations

89

H-Index

112

Concepts

All Affiliations

Memorial Sloan Kettering Cancer CenterCornell University
IG

About

Ian Ganly is an author at Memorial Sloan Kettering Cancer Center specializing in medicine, radiation oncology, and oncology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

46

84

8.6K

2

Health Sciences

22

26

1.7K

3

Engineering

1

1

17

4

Public Health

1

1

27

5

Biostatistics

1

1

51

Ian Ganly

×

265

Publications

28.6K

Citations

85

H-Index

YearCitations

Integrated Genomic Characterization of Papillary Thyroid Carcinoma

Nishant Agrawal, Rehan Akbani, Bülent Arman Aksoy,

Cell

2014

3K

Genomic and transcriptomic hallmarks of poorly differentiated and anaplastic thyroid cancers

Iñigo Landa, Tihana Ibrahimpašić, Laura Boucai,

Journal of Clinical Investigation

2016

1.2K

A controlled trial of intratumoral ONYX-015, a selectively-replicating adenovirus, in combination with cisplatin and 5-fluorouracil in patients with recurrent head and neck cancer

Fadlo R. Khuri, John Nemunaitis, Ian Ganly,

Nature Medicine

2000

1.1K

The head and neck cancer immune landscape and its immunotherapeutic implications

Rajarsi Mandal, Yasin Şenbabaoğlu, Alexis Desrichard,

JCI Insight

2016

773

Survival outcomes after treatment of cancer of the oral cavity (1985–2015)

Daniella K. Zanoni, Pablo H. Montero, Jocelyn Migliacci,

Oral Oncology

2019

479

Phase II Trial of Intratumoral Administration of ONYX-015, a Replication-Selective Adenovirus, in Patients With Refractory Head and Neck Cancer

John Nemunaitis, Fadlo R. Khuri, Ian Ganly,

Journal of Clinical Oncology

2001

472

Natural History and Tumor Volume Kinetics of Papillary Thyroid Cancers During Active Surveillance

R. Michael Tuttle, James A. Fagin, Gerald Minkowitz,

JAMA Otolaryngology–Head & Neck Surgery

2017

469

The mutational landscape of adenoid cystic carcinoma

Allen S. Ho, Kasthuri Kannan, David M. Roy,

Nature Genetics

2013

455

Frequent Somatic TERT Promoter Mutations in Thyroid Cancer: Higher Prevalence in Advanced Forms of the Disease

Iñigo Landa, Ian Ganly, Timothy A. Chan,

The Journal of Clinical Endocrinology & Metabolism

2013

454

A phase I study of Onyx-015, an E1B attenuated adenovirus, administered intratumorally to patients with recurrent head and neck cancer.

Ian Ganly, David H. Kirn, Gail Eckhardt,

PubMed

2000

439

Page 1